• Alnylam Pharmaceuticals average p/s ratio for 2024 was 13.12, a 21.34% increase from 2023.
• Alnylam Pharmaceuticals average p/s ratio for 2023 was 16.68, a 29.62% decline from 2022.
• Alnylam Pharmaceuticals average p/s ratio for 2022 was 23.7, a 14.38% decline from 2021.

P/s ratio can be defined as the price to sales or PS ratio is calculated by taking the latest closing price and dividing it by the most recent sales per share number. The PS ratio is an additional way to assess whether a stock is over or under valued and is used primarily in cases where earnings are negative and the PE ratio cannot be utilized.